Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition

Area of Science:

• Cardiology
• Transplantation Medicine
• Critical Care Medicine

Background:

• Heart transplantation is a vital treatment for end-stage heart failure.
• Primary allograft dysfunction (PGD) affects up to 40% of heart transplants, leading to poor patient outcomes.

Purpose of the Study:

• To propose and validate a clinical definition for primary allograft dysfunction (PGD) in heart transplantation.
• To assess the clinical outcomes associated with the proposed PGD definition.

Main Methods:

• A clinical definition for PGD was developed, focusing on impaired cardiac function and hemodynamic instability within 72 hours post-transplant.
• This definition was prospectively applied to 290 heart transplant recipients.
• Clinical outcomes were compared between patients meeting the PGD definition and those who did not.

Main Results:

• 32.4% of transplants met the PGD criteria.
• PGD patients required more inotropic support, mechanical circulatory support (including intra-aortic balloon pumps), and renal replacement therapy.
• PGD was associated with significantly longer intensive care unit stays and higher early (30-day and 1-year) mortality rates.

Conclusions:

• The proposed clinical definition for PGD is applicable in multicenter studies.
• Patients identified with PGD using this definition experienced more complications and increased mortality, highlighting its clinical significance.